Skip to main content
. 2020 Jul 7;11:1032. doi: 10.3389/fphar.2020.01032

Figure 7.

Figure 7

BTG1 inhibits allergic inflammation in vitro. (A) The indicated construct was transfected. The next day, cells were treated with DNP-specific IgE for 24 h, followed by treatment with DNP-HSA for 1 h. (B) β-hexosaminidase activity assays and qRT-PCR analysis were performed. ***p < 0.001. (C) Twenty-four hours after transfection, cells were treated without or with DNFB for 1 h, followed by immunoblot and qRT-PCR analysis. *p < 0.05; ***p < 0.001.